Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update

Keywords

Reteplase, Medicine, Streptokinase, Myocardial infarction, Tissue plasminogen activator

References

• Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial.Rolf Schröder, Karl Wegscheider, Klaus Schröder — 1995
• Fibrin-specific thrombolytic agents.Désiré Collen — 1988
• Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.Robert G. Wilcox — 1995
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)Robert G. Wilcox, Carl Olsson, Allan M. Skene — 1988
• Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsJohan Herlitz — 1994
• An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.The GUSTO Investigators — 1993
• Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?Frank Vermeer, Maarten L. Simoons, Frits W. Bär — 1986
• Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.Salim Yusuf, Robert T. Collins, Richard Peto — 1985
• The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.John W. Kennedy, G. V. Martin, Kathryn Davis — 1988
• Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.Christoph Bode, Richard W. Smalling, Günther Berg — 1996
• More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.Richard W. Smalling, Christoph Bode, John M. Kalbfleisch — 1995
• The management of acute myocardial infarction.J. P. Shillingford — 1971
• Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.Frans Van de Werf, Alphonso Arnold — 1988
• Bleeding during thrombolytic therapy for acute myocardial infarction: Mechanisms and managementPeter Pruett — 1990
• Thrombolytic Therapy in Acute Myocardial Infarction: A Review with Current RecommendationsRoger L. White — 1993
• The management of acute myocardial infarction.S Saltissi, Shukri S. Mushahwar — 1995
• Antiplatelet and anticoagulant use after myocardial infarctionGregory T. Almony, Jeffrey Lefkovits, Eric J. Topol — 1996
• Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.Valentı́n Fuster, Mark L. Dyken, Pantel Vokonas — 1993
• BM 06.022: A Novel Recombinant Plasminogen ActivatorUlrich Martin, Rainer Bader, Erwin Böhm — 1993
• Beta-blockers and sudden cardiac death.M. J. Kendall, Kevin P. Lynch, Ake Hjalmarson — 1995

Cited by

• Bone Mineral Density in Congenital Generalized Lipodystrophy: The Role of Bone Marrow Tissue, Adipokines, and Insulin ResistanceErika Bastos Lima Freire, Catarina Brasil d’Alva, Mayara Ponte Madeira — 2021

Related papers

• Choosing the Correct “-ase” in Acute Ischemic StrokeGeorge Dillon, Stacie Stevens, Wendy Dusenbury — 2019
• A Comparative Study of Thrombolytics Used for The Treatment of STEMI in a South Indian Tertiary Care HospitalAdhin Antony Xavier, R Chandana, Aleem Sarwar — 2016
• Comparative Efficacy between Streptokinase, Tenecteplase and Reteplase in ST Elevated Myocardial Infarction among Patients Attending Tertiary Care Hospital of OdishaLorika Sahu, Nirmal Kumar Mohanty, Siddhartha Goutam — 2022
• Fibrinolytic Agents for the Management of ST‐Segment Elevation Myocardial InfarctionDaniel E. Hilleman, James P. Tsikouris, A.Allen Seals — 2007
• Bolus fibrinolytic therapy in acute myocardial infarction.Joan Llevadot — 2001
• A Review of Available Fibrin‐Specific Thrombolytic Agents Used in Acute Myocardial InfarctionJames P. Tsikouris, Alexander P. Tsikouris — 2001
• Making a case for the right ‘-ase’ in acute ischemic stroke: alteplase, tenecteplase, and reteplaseKatleen Chester, Megan Corrigan, Juergen Schoeffler — 2019
• STAPHYLOKINASE: A BOON IN MEDICAL SCIENCES – REVIEWSeetha Ram Kotra, B J Peravali, Anmol Kumar — 2013
• CLINICAL EVALUATION OF REPERFUSION IN ST ELEVATION MYOCARDIAL INFARCTION WITH NON- INVASIVE MARKERS FOLLOWING THROMBOLYSIS WITH STREPTOKINASE VERSUS TENECTEPLASE.Shaila N Shah, Kalpesh Sukhwani, Vipul Prajapati — 2021
• Urgent need for the introduction of Tenecteplase in Pakistan: A Call to action for improved stroke and Mi Care.Mirza Rehan Yousaf, Hamza Naeem, Muhammad Bilal Shahid — 2023